VenoStent Technology Receives Breakthrough Device Designation by FDA
Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent,...
Staff
Proxima Clinical Research Earns 2022 Great Place to Work(R) Certification Amid Continued Growth and Promotions
96% of employees at Proxima CRO say it is a great place to work compared to 57% of employees at...
Scientific Industries Reports Financial Results for Third Quarter of Fiscal Year 2022
Bioprocessing Continues to Report Strong Revenue GrowthContinued Focus On Driving Digitally Simplified Bioprocessing GrowthInvestor Call to be held May 18th...
Report from the Annual General Meeting of Promore Pharma AB held on 17 May 2022
STOCKHOLM, SWEDEN / ACCESSWIRE / May 17, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)Promore Pharma AB, reg. no. 556639-6809, held its...
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
Click Here To RSVP for This In-Person, Outdoor EventHuman and Doggy Swag Will Be Available*, and the Event Will Feature...
Leafbuyer Technologies, Inc. Announces Q3 Results: 46% increase in Quarterly Revenue
Financial Highlights:Quarterly Revenue rose to $984,000 from $672,000 in the third quarter of fiscal year 2021Gross Profit increased to $292,682...
Gemina Labs Announces CE Mark for its First Product – The Best in Class Legio-X COVID Rapid Antigen Test
Less than two weeks after announcing the highly successful completion of human trials, Gemina has secured a European Union ("EU")...
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in...
Report from the Annual General Meeting of AlzeCure Pharma on 17 May 2022
STOCKHOLM, SE / ACCESSWIRE / May 17, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)Today, 17 May 2022, the annual general meeting...
StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / May 17, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare...
Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a...
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 – Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application
SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter...
H1 and Lightship Partner to Accelerate Clinical Studies with Diversity, Equity, and Inclusion Data
Leveraging H1’s Trial Landscape solution, Lightship will incorporate important diversity data into its clinical trials process, bringing life-changing therapies to...
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
New strains to provide crucial insights in mental health research across the sector Optimi Health Functional Mushrooms Optimi Health Lion's...
Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)
FDA granted IND clearance for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic...
Icario/Harris Poll Survey Uncovers Challenges Associated with Educating Medicaid Members on Redetermination and Re-enrollment
Findings Reaffirm Significant Disparities Between Higher-and Lower-Income Members, While Only 56% of Members Report Receiving Helpful Info About Medicaid Redetermination...
Virax Biolabs Introduces New Board of Directors, Announces Members
London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United...
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE)...
Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022
MIAMI, May 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for...